---
title: "Aveanna Healthcare Issues 2026 Outlook, Highlights Growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286570705.md"
description: "Aveanna Healthcare Holdings Inc. has released its 2026 financial outlook, projecting revenues of $2.56-$2.58 billion and adjusted EBITDA of $328-$332 million. The company anticipates a 9.4% annual revenue growth rate and highlights its strong national presence in pediatric homecare. Analysts rate AVAH stock as a Buy with a $9.50 price target, though concerns about high leverage and financial risk persist."
datetime: "2026-05-15T13:02:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286570705.md)
  - [en](https://longbridge.com/en/news/286570705.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286570705.md)
---

# Aveanna Healthcare Issues 2026 Outlook, Highlights Growth

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An update from Aveanna Healthcare Holdings ( (AVAH) ) is now available.

On May 15, 2026, Aveanna Healthcare Holdings Inc. released an investor presentation outlining its 2026 financial guidance and operating scale, projecting revenue of $2.56 billion to $2.58 billion, a year-to-date gross margin of 31.7%, and adjusted EBITDA of $328 million to $332 million. The presentation, which highlighted a 9.4% compound annual revenue growth rate from 2020 to 2026 and an annualized 48.2 million pediatric homecare hours as of the first quarter of 2026, underscored Aveanna’s strengthened national footprint and diversified payor mix, positioning the company as a significant player in cost-efficient, home-based care for payors and patients.

The most recent analyst rating on (AVAH) stock is a Buy with a $9.50 price target. To see the full list of analyst forecasts on Aveanna Healthcare Holdings stock, see the AVAH Stock Forecast page.

**Spark’s Take on AVAH Stock**

According to Spark, TipRanks’ AI Analyst, AVAH is a Neutral.

AVAH scores positively on valuation (very low P/E) and a supportive earnings update (raised 2026 guidance with strong Q1 execution), with improving short-term technical momentum. The primary constraint is financial risk from high leverage and a historically thin/negative equity base, which reduces durability if operating conditions soften.

To see Spark’s full report on AVAH stock, click here.

**More about Aveanna Healthcare Holdings**

Aveanna Healthcare Holdings Inc. is a U.S.-based home healthcare provider operating a scaled national platform with 379 locations across 39 states and a focus on homecare services, including extensive pediatric homecare hours. The company employs about 29,000 caregivers, works with 103 preferred payors, and maintains a diversified payor base in which no single payor accounts for more than 10% of total revenue.

**Average Trading Volume:** 1,336,341

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $1.62B

See more insights into AVAH stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [AVAH.US](https://longbridge.com/en/quote/AVAH.US.md)

## Related News & Research

- [Aveanna Healthcare Q1 revenue beats on PDS unit strength](https://longbridge.com/en/news/286405899.md)
- [Aveanna Healthcare Stock Is Up 23%. Here’s Why a Fund Still Sold $16 Million Worth](https://longbridge.com/en/news/285841693.md)
- [CHARBONE Releases Updated Presentation and Fact Sheet | CHHYF Stock News](https://longbridge.com/en/news/286251143.md)
- [Pharming publishes corporate presentation outlining rare disease portfolio, 2026 outlook](https://longbridge.com/en/news/286913175.md)
- [13:39 ETRodeo Dental & Orthodontics Expands Access to Affordable, Quality Dental Care in Glendale](https://longbridge.com/en/news/286804016.md)